Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Rottneros' Board of Directors proposes a dividend at an Extraordinary General Meeting

The Board of Rottneros AB (publ) (“Rottneros”) proposes a dividend of 0,45 SEK per share. In view of the uncertainty caused by the corona pandemic, Rottneros has not paid any dividends for the 2019 and 2020 financial years. At the same time, the Board has continuously analyzed the global situation, market conditions and the company's financial position to see if a dividend is possible.The upswing in the global pulp market began at the end of 2020. In 2021, demand has been strong and list prices have reached record levels. This has meant a good business development for Rottneros, which

Systemair AB Interim Report Q1 2021/22

Press Release, August 26, 2021 First quarter, May – July 2020 · Net sales increased by 9.1 percent to SEK 2,290 million (2,100). · Organic growth was 13.3 percent (-4.4). · Operating profit (EBIT) totalled SEK 210 million (182). · The operating margin was 9.2 percent (8.7). · Profit after tax amounted to SEK 157 million (82). · Earnings per share totalled SEK 2.98 (1.57). · Cash flow from operating activities amounted to SEK 159 million (235). Roland Kasper, President and CEO, comments: “The first quarter shows continued strong growth and margin improvement.

Invitation to information session of ChromoGenics interim report

ChromoGenics interim report for Q2 will be presented today, Thursday 26 August. On Monday 30 August, the company will hold a digital information event where shareholders and other stakeholders are invited to participate in a Q&A.On 30 August 19:00-20:00 CEST, the company’s newly appointed CEO Fredrik Fränding and Lars Ericsson, CFO & Head of Communications, will answer questions about the interim report, status and future plans. The chat will be available at the company’s website www.chromogenics.com. Questions and answers will also be available at the website after the event for a while

New Business Update - Ayima Group AB

Further to our recent update of 12 August, Ayima is today pleased to announce a further new contract win. The engagement signed to today totals approximately 1.7 MSek for the initial 4 month period to Dec 31 2021, but will automatically renew for a further 12 month period from Jan 1 2022. The client is a leading global brand in the online gaming sector and he services provided are for SEO consulting.  The latest wins bring the total of new contracts signed so far this year to approximately 52 MSek.

Additional analyses show robust treatment effect of the therapeutic vaccine Diamyd®

Diamyd Medical has, as part of interactions with regulatory agencies, conducted two new analyses on the large meta-analysis dataset of 627 individuals that participated in four previous placebo controlled clinical trials evaluating the efficacy and safety of the therapeutic diabetes vaccine Diamyd[®]. Both analyses support the clinical relevance and significance of the treatment benefits of Diamyd[®], which further support the design of the Phase III trial DIAGNODE-3 which is planned to start recruiting patients later this year.“These two analyses show the robustness of our data and provide

Versus Arthritis; Northern Ireland is “UK’S pain capital”, latest waiting times data confirms

Responding to the release this morning of  waiting times  data for elective surgery Sara Graham, Northern Ireland Director at the charity Versus Arthritis said:“ These figures confirm Northern Ireland’s place as the UK’s pain capital with the worst waiting times of anywhere in the country.  The data belies the daily reality of thousands of people with arthritis who are paying the price every day struggling to cope with persistent severe pain, worsening mental and physical health and reduced quality of life. “We’re hearing directly from people who have had their surgery cancelled that

MTG's holding of own shares exceeds five percent

STOCKHOLM, August 26, 2021 — Modern Times Group MTG AB’s (MTG) today announces that the company’s holding of own shares exceeds five percent.In accordance with the decision at the extraordinary general meeting on 28 July 2021, Modern Times Group MTG AB (publ) has repurchased 6,194,343 class C shares. The class C shares, which were issued in accordance with the decision at the extraordinary general meeting on 28 July 2021, were subscribed and paid for, and immediately repurchased from, Nordea Bank Abp. Modern Times Group MTG AB (publ) thereby holds 304,880 class B-shares and 6,324,343

LINK Arkitektur AS to design Construction City

Multiconsult (Oslo: MULTI) subsidiary LINK Arkitektur has entered into an agreement with Construction City Bygg AS to design the business cluster Construction City in Oslo, Norway. Total contract value for LINK Arkitektur is NOK 63 million.The contract is the continuation of a process that started in 2017 with a design competition and the completion of design development in May 2021. The contract includes construction documents and follow up during the construction period of Construction City. The project will start immediately and will be completed in second half of 2025.

2cureX publishes interim report for the second quarter and first half of 2021

2cureX AB (“2cureX”) hereby publishes the interim report for the second quarter and first half of 2021. The interim report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Fernando Andreu comments “Driven by the positive results of the TICC trial, and its pub­lication at the ASCO conference, we have accelerated the establishment of our commercial infrastructure in Europe to multiply the access to oncologists and pathologists and get a faster penetration in the market with our first product,

The environmental permit for project Kölvallen has gained legal force

The time period for seeking a leave to appeal has lapsed and thus the environmental permit for project Kölvallen has gained legal force. The environmental permit encompasses 43 turbines with a tip height of 220 metres, which corresponds to almost 300 MW of capacity considering currently available technology. The line concession and grid connection capacity are already available. Final project planning and procurement will now commence. This is expected to be completed towards the end of the year whereafter a sales process can be initiated. The goal is to finalise the sales process for

Ellinor Ehrnberg appointed as new President of the group company Smoltek Innovation AB

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has appointed Ellinor Ehrnberg as President of Smoltek Innovation AB, and she will assume this position on October 1. During the past year, Ellinor has held the position of business area manager of Smoltek Innovation, but she will now take on the role as President of the wholly owned group company.During the past year, Ellinor has held the position of business area manager and Head of the wholly owned

Baltic Sea Festival grand opening concert with Salonen and the Swedish Radio Symphony Orchestra

The Swedish Radio Symphony Orchestra with its Conductor Laureate Esa-Pekka Salonen open Baltic Sea Festival on 9 September 2021. Rebirth is the theme of the whole Festival and in its opening concert, both Anders Hillborg’s Kongsgaard Variations and Esa-Pekka Salonen’s Fog, reimagine classical masterpieces. Salonen’s programme culminates in Sibelius Second Symphony and its heavenly apotheosis. The theme of rebirth continues through the Festival with Klaus Mäkelä and Stravinsky’s Firebird Suite and Kaspars Putniņš Radio Choir programme focussing on the Baltic Seasons and the renewal of life.

Konftel In The Spotlight at Enterprise Connect

Konftel will showcase a series of powerful new innovations at Enterprise Connect, as part of an expanded product portfolio – highlighting how video is everywhere and everywhere is video!Konftel has developed a special room type guide  to help resellers and their customers pinpoint the most appropriate products and set-up - as part of its video solutions for every meeting room philosophy. The end-goal is video enabled meetings, always and everywhere - from personal workspaces, focus and huddle rooms to large multipurpose facilities. Konftel’s latest

Amendment Divio Technologies AB (Publ) has increased subscription revenue by 48% and reduced the loss with 52%

Amendment regarding MAR. Divio Technologies AB (Publ) has made a strong start to 2021, with a new sales team, and a new sales and marketing strategy, and growth continues to increase steadily. Subscription revenue has improved by 48% compared with the same period last year and net sales increased by 28%, and the figure is 40% if currency exchange effects are excluded. The company also reduced the loss with 52%. Amendment regarding MARSummary of the half-year report  For the period 1 January 2021 to 30 June 2021 · Net sales increased by 29%, or 40% FX adjusted to 8,096 (6,290) KSEK

Kemira Oyj: Announcement of manager’s transaction; CFO Petri Castrén has sold 7,000 Kemira shares

Kemira Oyj, Managers' transactions, August 26, 2021 at 11.30 am (EEST)Kemira Oyj: Announcement of manager’s transaction; CFO Petri Castrén has sold 7,000 Kemira shares  Kemira has received a notification from Petri Castrén, Chief Financial Officer, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.  Detailed information about the transaction is given below. Person subject to the notification requirement:Name: Castrén, PetriPosition: Chief Financial OfficerIssuer: KEMIRALEI: 74370031Y7RK5H88CQ48 Notification type: INITIAL

Norway Royal Salmon ASA (NRS): Last day in the acceptance period and update on number of acceptances received

Reference is made to the mandatory offer (the "Offer") from NTS ASA (the "Offeror") to acquire all shares in Norway Royal Salmon ASA ("NRS" or the "Company") pursuant to an offer document dated 16. July 2021, as amended by the announcement from the Offeror of 13 August 2021, at an offer price of NOK 240 per share (the “Offer”). The Offer Period Expires today, 26 August 2021 at 16:30 CEST (subject to further extension). Shareholders who wish to accept the Offer, and who has not already done this, must complete and accept the acceptance formular included in the Offer Document within 26 August

Nordic Iron Ore appoints ABB to provide automation and electrification planning for Blötberget

Nordic Iron Ore has appointed ABB to scope process control and management systems for a future-proof and fully-digitalized mining operation at the Blötberget iron ore mineGlobal technology company ABB has provided mine design consultancy and recommended scope of supply for the opening of the old Blötberget mine near Ludvika in the Dalarna region of Sweden. “Mining and the support industries are a significant part of the Swedish economy, with some of the most advanced and efficient mining operations anywhere in the world,” said Lennart Eliasson, Managing Director of Nordic Iron Ore. “

Sweco part of constructing the Crown Bridges tramway in Helsinki

Sweco is part of the alliance group that will construct the new Crown Bridges tramway in Helsinki, Finland. It will become Finland’s longest bridge. Work is expected to start this autumn.The Crown Bridges will connect Laajasalo, Korkeasaari and Kalasatama to the city center via three new bridges and a 10 km tramline. The new bridges are designed to cater tramway and light traffic. There will also be a new maritime route for cyclists and pedestrians. When completed in 2026, the Crown Bridges will with its 1,200 meters become the longest bridge in Finland.  Sweco has been a part of the

Read original

FluoGuide announces regulatory approval from Swedish Authorities (MPA and Ethics committee) to commence Phase II clinical trial with FG001 in guiding surgery of high grade glioma in Sweden

Copenhagen, Denmark, 26 August 2021 – FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to announce that the company has received regulatory approval for expanding the ongoing clinical phase I/II trial to Sweden with FG001.The ongoing clinical phase I/II trial with FG001 is designed as a two-phased trial, where the first phase aims to identify the optimal dose and investigate safety and tolerability. Phase II will provide efficacy data that will be used to design the following pivotal phase III trial intended to support regulatory approval of FG001 in high grade glioma, aggressive

ENGV new distributor for PowerCell Sweden AB in Australia and New Zealand

PowerCell Sweden AB (publ)  has signed an agreement with the Australian system integrator ENGV Pty Ltd, making ENGV the new distributor and service provider for PowerCell Sweden AB in the Australian and New Zealand markets.The two companies have been working together since 2020 when ENGV ordered an MS-100 fuel cell system from PowerCell for use in Australia’s first hydrogen stationary power demonstration plant in Denham, in remote Western Australia. ENGV is an integrator and a full-service provider meeting the needs of customers within all areas of gas and hydrogen

Norway Royal Salmon ASA (NRS) - Mandatory notification of trade

Charles Høstlund, CEO of Norway Royal Salmon ASA, has today sold 24,037 shares in Norway Royal Salmon ASA at a price of NOK 275.00 per share. Ola Loe, CFO of Norway Royal Salmon ASA, has today sold 195,361 shares in Norway Royal Salmon ASA at a price of NOK 275.00 per share. Ramsfjell AS, close associate to Ola Loe, CFO of Norway Royal Salmon ASA, has today sold 44,976 shares in Norway Royal Salmon ASA at a price of NOK 275.00 per share. Hatlebrekke Invest AS, close associate to Klaus Hatlebrekke, COO Business development of Norway Royal Salmon ASA, has today sold 150,485 shares in

BioStock Studio: Cereno’s CEO is looking forward to trial start

Gothenburg-based Cereno Scientific has made a number of preparations for the coming initiation of the phase II trial with their candidate CS1 in the rare cardiovascular disease PAH. CEO Sten R Sörensen visited BioStock’s studio to tell us more about this, the collaboration with Abbott, the coming subscription of TO1 and the expanded pipeline. Watch the interview, in Swedish, at biostock.se.Watch the interview with Cereno Scientific’s CEO Sten R Sörensen at biostock.se: https://www.biostock.se/en/2021/08/biostock-studio-cerenos-ceo-is-looking-forward-to-trial-start/ This is a press

South Africans show the world how social solidarity works: New Ranking Reveals the Most Privileged Countries

Study measures how privileged a nation is by examining levels of opportunities, freedom, health conditions, and financial independence through hundreds of data pointsThe German insights platform bestcasinosites.net has published the results of a study  which gives new insights into the most privileged countries in the world. The 44 countries selected for the study were examined using data provided by the United Nations, the World Bank, and many more. The findings highlight the countries who have the most privileges by

There are no items matching the current filter
There are no more items matching the current filter
Back to top